Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer02:18

Cancer

53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cationic carbon nanotube modulates surface fields for general acidic CO<sub>2</sub> reduction with aqueous organic cations.

Nature communications·2026
Same author

Anomaly detection and topology identification of distribution network based on conditional variational autoencoder.

Scientific reports·2026
Same author

lncRNA-EBLN3P promotes triple-negative breast cancer metastasis via activating Wnt/β-catenin signaling pathway.

Discover oncology·2026
Same author

Triptolide enhances lenvatinib sensitivity in hepatocellular carcinoma by regulating CERK-mediated sphingolipid-ferroptosis axis.

International immunopharmacology·2026
Same author

Transient Laser-Shocked Synthesis of Amorphous Layer-Supported Metal Nanocrystals for Efficient Nitrate Reduction.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Distillation Style Regulators and Semantic Prior-Guided Framework for Non-Ideal Single-View 3D Vehicle Point Cloud Reconstruction.

Sensors (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jan 14, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K

Cancer cachexia: molecular basis and therapeutic advances.

Yuting Tan1,2, Rui Xue1,2, Yuwei Pan1,2

  • 1School of Medicine, Chongqing University, Chongqing, PR China.

Signal Transduction and Targeted Therapy
|January 12, 2026
PubMed
Summary

Cancer cachexia involves complex interactions between tumors and the body, disrupting metabolism and inflammation. Targeting these pathways offers promising therapeutic strategies for patients.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

846

Related Experiment Videos

Last Updated: Jan 14, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

846

Area of Science:

  • Oncology
  • Metabolism
  • Immunology

Background:

  • Cancer cachexia affects 50-80% of cancer patients, significantly impacting morbidity.
  • The progression of cancer cachexia is not fully understood at organismal, cellular, and molecular levels.
  • Neoplastic cells and host interactions are critical in cancer cachexia pathogenesis.

Purpose of the Study:

  • To explore target organs and regulatory roles in cancer cachexia.
  • To examine macroenvironmental interactions and organismal crosstalk axes.
  • To summarize cellular and molecular networks driving cancer cachexia.

Main Methods:

  • Review of current literature on cancer cachexia.
  • Analysis of systemic metabolic remodeling and inflammatory responses.
  • Focus on cross-organismal, cellular, and molecular interactions.

Main Results:

  • Systemic metabolic remodeling is a hallmark, modulating tumor microenvironment inflammation.
  • Inflammatory responses disrupt energy metabolism in distant organs.
  • A vicious cycle exacerbates cachexia through mediator secretion and signaling pathways.

Conclusions:

  • Complex networks link metabolic reprogramming and inflammatory cascades in cancer cachexia.
  • Targeting metabolic remodeling and inflammation shows therapeutic promise.
  • Innovative strategies and clinical trials are underway to mitigate cancer cachexia.